# AstraZeneca Pharmaceuticals, LP – FDA Inspection, Jun 26, 2026

Source: https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/5b9f5d62-badb-435a-b322-32630163e2b4
Source feed: FDA_Inspections

> FDA inspection 1327360 of AstraZeneca Pharmaceuticals, LP, June 26, 2026. 1 citation under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1327360
- Company Name: AstraZeneca Pharmaceuticals, LP
- Inspection Date: 2026-06-26
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Philadelphia District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1236034 - 2024-04-26
- FDA Inspection 1211584 - 2023-07-19
- [FDA Inspection 1022686 - 2017-08-24](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f2212a7e-f3ac-42a5-ad63-1ca1b64cf950)
- [FDA Inspection 895233 - 2014-08-27](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/85d228df-13a6-44d7-8489-95ab6bab3f22)
- FDA Inspection 788561 - 2011-11-28

## Related Officers

- [Company Rep](https://www.keypedia.com/people/michael-o-idowu/795647ab-8f6b-47cc-ae88-3b2c61192861)
- [Yaharn Su](https://www.keypedia.com/people/yaharn-su/75b7f7fd-d853-436e-b538-386a8c6df3cb)

Company: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/ebec0358-60f4-4d3d-88a0-f03f946518ea

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8
